155 related articles for article (PubMed ID: 18596541)
21. PRDM1/Blimp1 downregulates expression of germinal center genes LMO2 and HGAL.
Cubedo E; Maurin M; Jiang X; Lossos IS; Wright KL
FEBS J; 2011 Sep; 278(17):3065-75. PubMed ID: 21722313
[TBL] [Abstract][Full Text] [Related]
22. Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways.
Booman M; Szuhai K; Rosenwald A; Hartmann E; Kluin-Nelemans H; de Jong D; Schuuring E; Kluin P
J Pathol; 2008 Oct; 216(2):209-17. PubMed ID: 18729069
[TBL] [Abstract][Full Text] [Related]
23. Comparative clinicopathological study of primary CNS diffuse large B-cell lymphoma and intravascular large B-cell lymphoma.
Imai H; Shimada K; Shimada S; Abe M; Okamoto M; Kitamura K; Kinoshita T; Shiraishi T; Nakamura S
Pathol Int; 2009 Jul; 59(7):431-7. PubMed ID: 19563405
[TBL] [Abstract][Full Text] [Related]
24. Endothelial hyperplasia and endothelial galectin-3 expression are prognostic factors in primary central nervous system lymphomas.
D'Haene N; Catteau X; Maris C; Martin B; Salmon I; Decaestecker C
Br J Haematol; 2008 Feb; 140(4):402-10. PubMed ID: 18081894
[TBL] [Abstract][Full Text] [Related]
25. Genetic evidence implies that primary and relapsed tumors arise from common precursor cells in primary central nervous system lymphoma.
Hattori K; Sakata-Yanagimoto M; Kusakabe M; Nanmoku T; Suehara Y; Matsuoka R; Noguchi M; Yokoyama Y; Kato T; Kurita N; Nishikii H; Obara N; Takano S; Ishikawa E; Matsumura A; Muratani M; Hasegawa Y; Chiba S
Cancer Sci; 2019 Jan; 110(1):401-407. PubMed ID: 30353605
[TBL] [Abstract][Full Text] [Related]
26. Somatically mutated immunoglobulin IGHV@ genes without intraclonal heterogeneity indicate a postgerminal centre origin of primary intraocular diffuse large B-cell lymphomas.
Malumbres R; Davis J; Ruiz P; Lossos IS
Br J Haematol; 2007 Sep; 138(6):749-55. PubMed ID: 17760806
[TBL] [Abstract][Full Text] [Related]
27. Expression of cyclooxygenase-2 and vascular endothelial growth factor in primary central nervous system lymphomas.
Sugita Y; Komatani H; Ohshima K; Shigemori M; Nakashima A
Oncol Rep; 2007 Sep; 18(3):617-22. PubMed ID: 17671709
[TBL] [Abstract][Full Text] [Related]
28. Immunoglobulin repertoire of primary lymphomas of the central nervous system.
Montesinos-Rongen M; Purschke F; Küppers R; Deckert M
J Neuropathol Exp Neurol; 2014 Dec; 73(12):1116-25. PubMed ID: 25383641
[TBL] [Abstract][Full Text] [Related]
29. Pathology and genetics of primary central nervous system and intraocular lymphoma.
Rubenstein JL; Treseler P; O'Brien JM
Hematol Oncol Clin North Am; 2005 Aug; 19(4):705-17, vii. PubMed ID: 16083831
[TBL] [Abstract][Full Text] [Related]
30. Primary mediastinal large B-cell lymphoma.
Martelli M; Ferreri AJ; Johnson P
Crit Rev Oncol Hematol; 2008 Dec; 68(3):256-63. PubMed ID: 18774728
[TBL] [Abstract][Full Text] [Related]
31. Identification of CD20 C-terminal deletion mutations associated with loss of CD20 expression in non-Hodgkin's lymphoma.
Terui Y; Mishima Y; Sugimura N; Kojima K; Sakurai T; Mishima Y; Kuniyoshi R; Taniyama A; Yokoyama M; Sakajiri S; Takeuchi K; Watanabe C; Takahashi S; Ito Y; Hatake K
Clin Cancer Res; 2009 Apr; 15(7):2523-30. PubMed ID: 19276251
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic down-regulation of the tumor suppressor gene PRDM1/Blimp-1 in diffuse large B cell lymphomas: a potential role of the microRNA let-7.
Nie K; Zhang T; Allawi H; Gomez M; Liu Y; Chadburn A; Wang YL; Knowles DM; Tam W
Am J Pathol; 2010 Sep; 177(3):1470-9. PubMed ID: 20651244
[TBL] [Abstract][Full Text] [Related]
33. Expression pattern and cellular sources of chemokines in primary central nervous system lymphoma.
Brunn A; Montesinos-Rongen M; Strack A; Reifenberger G; Mawrin C; Schaller C; Deckert M
Acta Neuropathol; 2007 Sep; 114(3):271-6. PubMed ID: 17641901
[TBL] [Abstract][Full Text] [Related]
34. Blimp1: a conserved transcriptional repressor critical for differentiation of many tissues.
John SA; Garrett-Sinha LA
Exp Cell Res; 2009 Apr; 315(7):1077-84. PubMed ID: 19073176
[TBL] [Abstract][Full Text] [Related]
35. Translocation t(11;18)(q21;q21) in gastric B-cell lymphomas.
Toracchio S; Ota H; de Jong D; Wotherspoon A; Rugge M; Graham DY; Samani A; El-Zimaity HM
Cancer Sci; 2009 May; 100(5):881-7. PubMed ID: 19320643
[TBL] [Abstract][Full Text] [Related]
36. Neural cell adhesion molecule (CD56)-positive B-cell lymphoma.
Isobe Y; Sugimoto K; Takeuchi K; Ando J; Masuda A; Mori T; Oshimi K
Eur J Haematol; 2007 Aug; 79(2):166-9. PubMed ID: 17635242
[TBL] [Abstract][Full Text] [Related]
37. Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging.
Liao W; Liu Y; Wang X; Jiang X; Tang B; Fang J; Chen C; Hu Z
Acta Radiol; 2009 Mar; 50(2):217-25. PubMed ID: 19096950
[TBL] [Abstract][Full Text] [Related]
38. Splenic follicular lymphoma: clinicopathologic characteristics of a series of 32 cases.
Mollejo M; Rodríguez-Pinilla MS; Montes-Moreno S; Algara P; Dogan A; Cigudosa JC; Juarez R; Flores T; Forteza J; Arribas A; Piris MA
Am J Surg Pathol; 2009 May; 33(5):730-8. PubMed ID: 19194277
[TBL] [Abstract][Full Text] [Related]
39. Terminal differentiation of lymphocytes depends on Blimp-1.
Kallies A; Nutt SL
Curr Opin Immunol; 2007 Apr; 19(2):156-62. PubMed ID: 17291741
[TBL] [Abstract][Full Text] [Related]
40. Frequent inactivation of CDKN2A and rare mutation of TP53 in PCNSL.
Cobbers JM; Wolter M; Reifenberger J; Ring GU; Jessen F; An HX; Niederacher D; Schmidt EE; Ichimura K; Floeth F; Kirsch L; Borchard F; Louis DN; Collins VP; Reifenberger G
Brain Pathol; 1998 Apr; 8(2):263-76. PubMed ID: 9546285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
